Scholars Central

EditorialPublished 29 Sep 2023

Targeted Therapies for Soft Tissue Sarcoma: New Horizons in Treatment

Authors: Rhys Moorish

Department of Radiology, University Hospital Essen, Germany

Journal of Orthopedic Oncology

Volume 9 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Soft tissue sarcoma (STS) encompasses a diverse group of rare and challenging malignancies originating from soft tissues. Historically, treatment options have been limited to surgery, radiation, and chemotherapy, often yielding suboptimal outcomes. However, the emergence of targeted therapies has revolutionized the landscape of STS treatment, offering new horizons and renewed hope for patients and clinicians alike. Targeted therapies represent a class of treatments designed to selectively target specific molecular abnormalities or pathways essential for tumor growth and survival. By honing in on these unique molecular targets, targeted therapies aim to achieve higher efficacy with reduced systemic toxicity compared to conventional chemotherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Orthopedic Oncology
  • SubjectOncology & Cancer
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Rhys Moorish”